The ocean deep holds untapped potential when it comes to new therapies that could treat diseases like cancer and Alzheimer’s. But climate change and…
The Alzheimer’s Drug, Oligomannate, approved in China and derived from seaweed, is now being studied in the U.S. in a Phase 3, multi-center clinical…
An experimental “seaweed” drug called Oligomannate, which treats Alzheimer’s, is now available for patients to buy in China. Chinese officials announced conditional approval to…
Was it too good to be true? China last week awarded conditional approval for a new seaweed-based drug for Alzheimer’s, but experts in the…
Building on research into the connection between dementia, inflammation and bacteria in our digestive systems, Chinese officials awarded conditional approval to a seaweed-based drug…